Abstract
dc:descriptionPhotodynamic Therapy (PDT) is a modern and targeted anticancer approach based on the combined action of photosensitizers (PSs), light irradiation of an appropriate wavelength, and molecular oxygen. Upon activation, PSs generate reactive oxygen species (ROS), with singlet oxygen (1O₂) being the predominant cytotoxic agent, causing extensive damage to critical cellular structures and ultimately inducing apoptosis or necrosis. Compared to conventional chemotherapy and radiotherapy, PDT offers enhanced selectivity and reduced systemic toxicity, as the therapeutic action is locally triggered by light. A key challenge for the further advancement of PDT lies in the rational design of novel photosensitizers with improved efficiency, controlled photochemistry, and integrated diagnostic capabilities. In this context, coordination complexes of transition metals—particularly ruthenium (Ru) and iridium (Ir)—have emerged as highly promising candidates. Ru(II) complexes exhibit high thermodynamic and photochemical stability, intense metal-to-ligand charge-transfer (MLCT) transitions, strong absorption in the visible region, and emission in the near-infrared (NIR) range, rendering them suitable for theranostic applications. Similarly, Ir(III) and Pt(II) complexes display outstanding photophysical properties, with their photodynamic behavior being tunable through modification of the ligand environment. Special emphasis is placed on the investigation of photoactivatable complexes capable of releasing bioactive gaseous molecules, such as carbon monoxide (CO) and nitric oxide (NO). Computational analysis demonstrated that the photodissociation of the Ru–CO bond can be reliably predicted using trans-philicity descriptors, while bond stability is governed by a delicate balance between σ-donation and π-back-donation. Photodissociation proceeds via a triplet metal-centered (3MC) excited state with a low activation barrier, confirming the dual therapeutic and diagnostic role of Ru(II) photoCORMs. Similarly, for Ru–NO systems, it was shown that the photosensitivity of the Ru–NO bond is controlled by the energy gap between the ground and excited states, in accordance with the Energy Gap Law. Smaller energy gaps favor photodissociation, rendering the Ru–NO bond suitable for controlled NO release. Hybridization of these complexes with gold nanoparticles significantly alters their optical, structural, and electronic properties, increasing polarizability and introducing new photoexcitation pathways.Density Functional Theory (DFT) and Time-Dependent DFT (TD-DFT) calculations accurately reproduced the geometries and spectra of the systems in different electronic states, while variations in refractive index and spectral features confirmed the impact of nanomaterials on photochemistry and photoinduced molecular rearrangement. Molecular orbital analysis further elucidated the role of orbital overlap in shaping the observed photophysical behavior.In parallel, the application of multivariate data analysis methods (PCA, QSAR, QSPR) enabled the discrimination of dominant photodynamic mechanisms. The first principal component (PC1) was associated with redox descriptors and Type I pathways, leading to ROS generation and DNA damage, whereas the second principal component (PC2) correlated with steric and polarizability descriptors, favoring Type II mechanisms and singlet oxygen production. Ru complexes were found to preferentially activate Type I mechanisms due to their strong redox and charge-transfer characteristics, while Ir and Pt complexes exhibited a tendency toward Type II pathways, where geometric and polarizability factors play a dominant role. Overall, this dissertation demonstrates that the integration of quantum chemical calculations, inorganic chemistry, and pharmacologically relevant endpoints leads to the formulation of clear and predictive design rules for photodynamic agents. The choice of the metal center and the ligand environment determines the dominant mechanism of action (Type I or Type II), photodynamic efficiency, dark toxicity, and diagnostic capability, paving the way for the development of novel, multifunctional, and selective theranostic systems for anticancer applications.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katevas, Nikolaos
- Κατέβας, Νικόλαος
Subjects
dc:subject × 16- Φωτοδυναμική θεραπεία
- Καρκίνος
- Θεωρία συναρτησιακής πυκνότητας
- Σύμπλοκα μεταβατικών μετάλλων
- Θερανοστικά
- Photodynamic therapy
- Cancer
- Density functional theory (DFT)
- Transition metal complexes
- Theranostics
- Χημεία
- Φυσικές Επιστήμες
- Φυσική και Θεωρητική χημεία
- Chemical Sciences
- Natural Sciences
- Physical and Theoretical Chemistry
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60614